
Constipation and reflux on the Wegovy pill
A slower stomach, says the label, and the three effects that follow: constipation, reflux, indigestion, with their rates.
Oolite Learn
Every question we could find about the GLP-1 pill, answered from the prescribing information. Updated as the labels change.

A slower stomach, says the label, and the three effects that follow: constipation, reflux, indigestion, with their rates.

About 9 percent, and the gap halves each week. What one skipped day does in a model built on the label's half-life, and what the label says about choosing to skip.

Two percent with type 2 diabetes, seven with a sulfonylurea, under one without diabetes. The label's numbers and its list of signs.

The label's table, strength by strength: nausea, constipation, diarrhea, vomiting, and the sentence about escalation.

Eleven percent versus five, says the label. The effect people are least prepared for, and what the label does and does not say about it.

The most common side effect, the numbers the label reports, and the two things it says to do about it.

No morning window, no water rule, no waiting. What the label does ask for, and why a fixed time helps with this molecule.

The gym does not change the label. The tablet, the sip, the 30 minutes, then the water bottle.

The label says morning and empty stomach, not seven o'clock. What the short-fast data says, and what to ask your prescriber.

Time zones, hotel breakfasts, the bottle in the suitcase. What the label asks for, and the one thing it never mentions.

The label wants the tablet in its bottle until the morning it is taken. Here is why, and what people use instead.

Room temperature, and nothing about light any more: what the July 2026 label changed, and the range that is safe on a hot day.

What the label says the first days are: 0.8 mg, any time, settled in a week, stomach effects higher during the escalation.

Three fixed steps, then three the prescriber chooses. At least 30 days each, 17.2 mg at most.

Thirty days a step, why the label escalates, and the two exits it writes down.

Same tablet, a schedule that stops at 4 mg. What the plan is, what the label says a step is for.

The pill first, 30 minutes, then the rest. And the 33 percent the label reports for levothyroxine.

Fibre, collagen, magnesium, the multivitamin: all of it waits 30 minutes, and the label's reason why.

With or without food, says the label, and here is the study behind those four words.

Take it as soon as you remember, never double up, and a seven day rule the Wegovy pill does not have.

A one week half-life, five to seven weeks to clear, four to five weeks to build. The label's numbers, drawn.

A sevenfold spread in the label's own numbers. Why the tablet varies more than the injection, and what it means for comparing notes.

Thirty days at 1.5, thirty at 4, then 4 or 9. The label's schedule for the tablet that replaced Rybelsus.

Same tablet, new name, half the dose numbers. The mapping, step by step.

Not a second tablet, not a wasted week: what the label and the food study say about the one morning that went wrong.

Skip it, take the next one tomorrow. The label's sentence, and what one day does to the level.

A third of a glass, two and a half shot glasses, 120 millilitres. Where the ceiling comes from and how people measure it.

Why the label says up to 4 ounces, and what a bigger glass did in the manufacturer's tests.

Water only, 4 ounces, 30 minutes. What the label says, and what the morning looks like in practice.

One to two percent, says the label, against 89 for the injection. The number behind every morning rule.
Tool
The pill level chart
How the Wegovy pill, Ozempic tablets or Foundayo build up day by day, what a missed morning costs, how long the pill lingers. From the label's half-life, no sign-up.
By pill
Oolite
The GLP-1 tracker for the pill and the shot.
The 30 minute timer, your shot day, the level chart and the dose reminder, on iPhone, with Apple Watch to log. Free to download, then a 14-day free trial.